Get a glimpse from Providence, KP and CVS Health leaders of what you can learn from their sessions at Reuters Events: Digital Health! Read more
Sandoz receives approval by European Commission for Hyrimoz (adalimumab) high-concentration formulation Read more
BioNTech and DualityBio Form Global Strategic Partnership to Accelerate Development of Differentiated Antibody-Drug Conjugate Therapeutics for Solid Tumors Read more
FDA Approves Merck’s KEYTRUDA (pembrolizumab) in Combination With Padcev (enfortumab vedotin-ejfv) for First-Line Treatment of Certain Patients With Locally Advanced or Metastatic Urothelial Cancer Read more
License agreement with KYM Biosciences for CMG901, a Claudin-18.2 antibody drug conjugate, completed Read more
GSK and SCYNEXIS announce an exclusive agreement to commercialise and further develop Brexafemme (ibrexafungerp), a novel, first-in-class medicine to treat fungal infection Read more
Moderna Finalizes Agreement with the Government of the Republic of Kenya to Establish an mRNA Manufacturing Facility Read more